This content is machine translated SARS-CoV-2 How Covid-19 leads to neuronal damage A proportion of patients suffer from persistent symptoms after acute covid-19 disease. Neurological symptoms are often in the foreground. Although SARS-CoV-2 does not affect nerve cells, covid-19 disease can cause…
View Post 4 min This content is machine translated Brain (nerve) diseases Recognizing deficits in vestibular paroxysmia, multiple sclerosis and co. The central nervous system is permanently exposed to a variety of challenges. Some hurdles can be overcome; others require help. Researchers are working at full speed to decipher processes in…
View Post 6 min This content is machine translated Long-Covid “Brain Fog” – Case series with Ginkgo biloba shows encouraging results A team led by the neurologist and psychiatrist Prim. Univ.-Doz. Dr. Udo Zifko conducted a case series at the neurological Post-Covid Outpatient Clinic headed by him. In patients suffering from…
View Post 12 min This content is machine translated Parkinson's disease Optimization of L-dopa therapy at the onset of effect fluctuations. Levodopa is still considered the gold standard in the treatment of Parkinson’s disease. Among them, good symptom control with a high quality of life can be achieved for the patient… CME-Test
View Post 3 min This content is machine translated Multiple Sclerosis: RRMS Therapy change – strategy for follow-up treatment Until the individually appropriate disease-modifying therapy (DMT) is available, there arein the absence of predictive biomarkers, stepwise optimizations are often necessary, possibly resulting in multiple changes of DMT. To reduce…
View Post 12 min This content is machine translated Parkinson's disease Optimization of L-dopa therapy at the onset of effect fluctuations Levodopa is still considered the gold standard in the treatment of Parkinson’s disease. Among them, good symptom control with a high quality of life can be achieved for the patient… CME-Test
View Post 9 min This content is machine translated Sponsored Content: PARKINSON DISEASE (PD) Tailored therapy for motor fluctuations At the EAN Congress 2022, a Bial satellite symposium discussed treatment options for motor fluctuations and presented new data on the pharmacokinetics of levodopa in combination with the COMT inhibitor…
View Post 5 min This content is machine translated Guideline recommendations 2022 Update on secondary prevention of ischemic stroke and TIA. This year, the German Society of Neurology (DGN) and the German Stroke Society (DSG) published the new S2k guideline ‘Secondary prevention of ischemic stroke and transient ischemic attack’. This contains…
View Post 9 min This content is machine translated Pain Assessment The basis for individual therapy Historically, neuropathic pain has been classified based on the underlying etiology. However, given the heterogeneity of pain mechanisms, other classification schemes may be more appropriate. In this case, the individual…
View Post 4 min This content is machine translated Restless legs syndrome: guideline update Substitute iron deficiency and always use dopaminergics judiciously The diagnostic criteria for restless legs syndrome (RLS) were revised and agreed upon in a consensus conference. The previous division into primary and secondary forms of RLS has been replaced…
View Post 3 min This content is machine translated Parkinson's Good sleep despite stressful illness In Parkinson’s disease, the individual, symptomatic therapy is crucial for the quality of life. This should be initiated as early as possible. This is because it can delay or even prevent…
